22
May
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
21
May
OTHERS
Duopharma Biotech Contributes to National Pharmaceutical Self-Reliance Through Manufacturing Capacity and Portfolio Growth
21
May
General Meetings: Outcome of Meeting
20
May
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
14
May
OTHERS
Duopharma Biotech sees profit growth in Q1FY2026 alongside insulin supply normalisation
14
May
Quarterly rpt on consolidated results for the financial period ended 31/03/2026
04
May
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - YAYASAN PELABURAN BUMIPUTRA
04
May
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - PERMODALAN NASIONAL BERHAD
21
Apr
Annual Audited Accounts - 31 Dec 2025
21
Apr
Annual Report & CG Report - 2025
20
Apr
General Meetings: Notice of Meeting
31
Mar
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
24
Mar
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
19
Mar
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
10
Mar
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
09
Mar
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
06
Mar
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
05
Mar
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
05
Mar
MATERIAL LITIGATION
MATERIAL LITIGATION KUALA LUMPUR HIGH COURT CIVIL SUIT NO. WA-22IP-15-02/2025 - WRIT OF SUMMONS AND STATEMENT OF CLAIM SERVED ON DUOPHARMA MANUFACTURING (BANGI) SDN. BHD. (A WHOLLY-OWNED SUBSIDIARY OF DUOPHARMA BIOTECH BERHAD) BY SUN PHARMACEUTICAL INDUSTRIES LIMITED
04
Mar
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - LEMBAGA TABUNG HAJI
04
Mar
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
03
Mar
Notice of Interest Sub. S-hldr (Section 137 of CA 2016) - LEMBAGA TABUNG HAJI
03
Mar
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
02
Mar
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
27
Feb
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
27
Feb
DPHARMA - Notice of Book Closure
26
Feb
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
26
Feb
OTHERS
Duopharma Biotech maintains robust revenue and profit growth momentum
26
Feb
Second Interim Dividend
26
Feb
Quarterly rpt on consolidated results for the financial period ended 31/12/2025